CEFTRIAXONE News
CEFTRIAXONE currently has 0 news articles, with 34 predicted indications.
This page combines the AI-predicted indications for CEFTRIAXONE with the latest health news. Indications highlighted in orange have recent news coverage.
Drug Information
- Evidence level: L5
- Predicted indications (34):
- pneumococcal meningitis (99.0%)
- streptococcal pneumonia (99.0%)
- salmonellosis (99.0%)
- rhinoscleroma (99.0%)
- streptococcal infection (99.0%)
- arthropathy (99.0%)
- chancroid (99.0%)
- viral meningitis (99.0%)
- Peptostreptococcus infectious disease (99.0%)
- bacterial arthritis (99.0%)
- meningococcal infection (99.0%)
- gonorrhea (99.0%)
- gonococcal infection of joint (99.0%)
- lymphogranuloma venereum (99.0%)
- bacterial meningitis (99.0%)
- acute gonococcal cervicitis (99.0%)
- acute gonococcal endometritis (99.0%)
- Escherichia coli meningitis (99.0%)
- escherichia coli infection (99.0%)
- bacterial pneumonia (99.0%)
- invasive non-typhoidal salmonellosis (99.0%)
- streptococcal meningitis (99.0%)
- endometritis (99.0%)
- necrotizing ulcerative gingivitis (99.0%)
- leptospirosis (99.0%)
- staphylococcal pneumonia (99.0%)
- yaws (99.0%)
- polyclonal hyperviscosity syndrome (99.4%)
- hyperamylasemia (99.4%)
- congenital analbuminemia (99.4%)
- infectious otitis media (99.3%)
- blood group incompatibility (99.1%)
- suppurative otitis media (99.0%)
- chronic otitis media (99.0%)
Related News (0)
No related news yet. When news mentions this drug, it will be collected and shown here automatically.
Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.